Valuation: Photocure ASA

Market Cap 152.08Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.54TCr 23Cr 153.2Cr 60Cr 771.43Cr 60Cr 59Cr 2.56TCr P/E 2026 *
20x
P/E 2027 * 72.4x
Enterprise Value 135.18Cr 14Cr 12Cr 12Cr 11Cr 20Cr 1.37TCr 20Cr 136.18Cr 53Cr 685.71Cr 54Cr 53Cr 2.28TCr EV / Sales 2026 *
2.05x
EV / Sales 2027 * 2.05x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+5.61%
1 week+9.71%
Current month+6.60%
1 month-2.59%
3 months-9.89%
6 months-10.32%
Current year-20.87%
1 week 51.6
Extreme 51.6
57.9
1 month 46.25
Extreme 46.25
58.6
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Human Resources Officer - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/04/25 BuyCompany 11,355 0.0419%
02/04/25 BuyCompany 8,997 0.0332%
31/03/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
+5.61%+9.71%-8.72%+33.41% 16Cr
-2.25%-0.47%+68.30%+115.90% 1,05200Cr
-0.66%+0.43%+47.39%+50.54% 63TCr
-0.54%+1.39%+20.69%+63.99% 44TCr
-1.99%-3.32%+38.71%+35.41% 35TCr
-1.05%-2.81%+23.07%+35.70% 29TCr
-2.12%-3.67%-1.14%+5.37% 24TCr
-0.63%+1.04%+40.05%+56.09% 22TCr
-1.19%-3.41%-9.57%-52.71% 20TCr
+0.16%+3.87%+16.89%+73.73% 17TCr
Average -0.47%+0.80%+23.57%+41.74% 35.95TCr
Weighted average by Cap. -1.36%+0.32%+39.09%+61.29%

Financials

2026 *2027 *
Net sales 66Cr 6.97Cr 6.02Cr 5.66Cr 5.15Cr 9.68Cr 666.87Cr 9.84Cr 66Cr 26Cr 333.94Cr 26Cr 26Cr 1.11TCr 67Cr 7.06Cr 6.1Cr 5.73Cr 5.21Cr 9.8Cr 674.97Cr 9.96Cr 67Cr 26Cr 338Cr 27Cr 26Cr 1.12TCr
Net income 7.63Cr 80.86L 69.84L 65.63L 59.69L 1.12Cr 77Cr 1.14Cr 7.69Cr 3.01Cr 39Cr 3.04Cr 2.97Cr 128.67Cr 2.1Cr 22.25L 19.21L 18.06L 16.42L 30.87L 21Cr 31.38L 2.12Cr 82.72L 11Cr 83.52L 81.71L 35Cr
Net Debt -17Cr -1.79Cr -1.55Cr -1.45Cr -1.32Cr -2.48Cr -171.19Cr -2.53Cr -17Cr -6.66Cr -86Cr -6.72Cr -6.58Cr -284.88Cr -16Cr -1.66Cr -1.44Cr -1.35Cr -1.23Cr -2.31Cr -159.03Cr -2.35Cr -16Cr -6.18Cr -80Cr -6.24Cr -6.11Cr -264.65Cr
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
14/26/14 NOK 56.50 +5.61% 3,49,944
13/26/13 NOK 53.50 +1.52% 58,141
12/26/12 NOK 52.70 +1.15% 40,740
11/26/11 NOK 52.10 -0.95% 34,469
10/26/10 NOK 52.60 +2.14% 45,311
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
56.50NOK
Average target price
79.67NOK
Spread / Average Target
+41.00%

Quarterly revenue - Rate of surprise